GlassScriptPhysician profile
Nathan P Cohen
NPI 1285686774
$850.62
in general payments reported to CMS, 2019-2025
15 companies · $19.28 in 2025
The $19.28 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $72.94 · 2020: $148 · 2021: $384 · 2022: $52.26 · 2023: $126 · 2024: $48.05 · 2025: $19.28.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $193.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $193.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $280.71 | 2021-2023 | Enseal |
| Sanara Medtech INC. | $148.14 | 2020 | |
| Anika Therapeutics, INC. | $114.20 | 2021 | |
| Pacira Therapeutics, INC. | $45.23 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $44.61 | 2019-2023 | |
| Pacira Pharmaceuticals Incorporated | $38.46 | 2021-2022 | |
| Stryker Corporation | $33.91 | 2024 | Mako |
| Bioventus LLC | $27.00 | 2019-2024 | Exogen Ultrasound Bone Healing System |
| Dynasplint Systems INC. | $20.71 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $19.28 | 2025 | |
| Smith+Nephew, INC. | $18.26 | 2023 | Collagenase Santyl, Regranex |
| Abbvie INC. | $17.93 | 2022 | |
| Kerecis Limited | $16.62 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Owens & Minor | $14.34 | 2023 | |
| Axogen | $11.22 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nathan Cohen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.